GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon H. Guyatt,Andrew D Oxman,Gunn Elisabeth Vist,Regina Kunz,Yngve Falck-Ytter,Pablo Alonso-Coello,Holger J. Schünemann +6 more
Reads0
Chats0
TLDR
The advantages of the GRADE system are explored, which is increasingly being adopted by organisations worldwide and which is often praised for its high level of consistency.Abstract:
Guidelines are inconsistent in how they rate the quality of evidence and the strength of recommendations. This article explores the advantages of the GRADE system, which is increasingly being adopted by organisations worldwideread more
Citations
More filters
Journal ArticleDOI
GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions
Nancy Santesso,Claire Glenton,Philipp Dahm,Paul Garner,Elie A. Akl,Brian S. Alper,Romina Brignardello-Petersen,Alonso Carrasco-Labra,Hans de Beer,Monica Hultcrantz,Ton Kuijpers,Joerg J Meerpohl,Rebecca L. Morgan,Reem A. Mustafa,Nicole Skoetz,Shahnaz Sultan,Charles Shey Wiysonge,Gordon H. Guyatt,Holger J. Schünemann +18 more
TL;DR: An approach that improves the clarity of statements to convey findings and that draws on Grading of Recommendations Assessment, Development and Evaluation is developed.
Journal ArticleDOI
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia.
Adam Cuker,Gowthami M. Arepally,Beng H. Chong,Douglas B. Cines,Andreas Greinacher,Yves Gruel,Lori A. Linkins,Stephen B. Rodner,Sixten Selleng,Theodore E. Warkentin,Ashleigh Wex,Reem A. Mustafa,Reem A. Mustafa,Rebecca L. Morgan,Nancy Santesso +14 more
TL;DR: These evidence-based guidelines of the American Society of Hematology are intended to support patients, clinicians, and other health care professionals in their decisions about diagnosis and management of HIT.
Journal ArticleDOI
2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
Lenore Buckley,Gordon Guyatt,Howard A Fink,Michael Cannon,Jennifer M. Grossman,Karen E. Hansen,Mary Beth Humphrey,Nancy E Lane,Marina Magrey,Marc Miller,Lake Morrison,Madhumathi Rao,Angela Byun Robinson,Sumona Saha,Susan Wolver,Raveendhara R. Bannuru,Elizaveta E. Vaysbrot,Mikala C. Osani,Marat Turgunbaev,Amy S. Miller,Timothy E. McAlindon +20 more
TL;DR: To develop recommendations for prevention and treatment of glucocorticoid‐induced osteoporosis (GIOP).
Journal ArticleDOI
The EAACI/GA 2 LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update
Torsten Zuberbier,Werner Aberer,Riccardo Asero,Carsten Bindslev-Jensen,Zenon Brzoza,Giorgio Walter Canonica,Martin K. Church,Luis Felipe Ensina,Ana Giménez-Arnau,Kiran Godse,Margarida Gonçalo,Clive Grattan,Jacques Hébert,Michihiro Hide,Allen P. Kaplan,Alexander Kapp,A H Abdul Latiff,P. Mathelier-Fusade,Martin Metz,Alexander Nast,Sarbjit S. Saini,Mario Sánchez-Borges,Peter Schmid-Grendelmeier,F. E. R. Simons,Petra Staubach,Gordon Sussman,Elias Toubi,Gino A. Vena,Bettina Wedi,X J Zhu,Markus Maurer +30 more
TL;DR: This guideline covers the definition and classification of urticaria, taking into account the recent progress in identifying its causes, eliciting factors and pathomecha.
Journal ArticleDOI
An assessment by the Statin Muscle Safety Task Force: 2014 update
TL;DR: An algorithm is developed for the evaluation and treatment of patients who may be intolerant to statins as the result of adverse muscle events and guidance as to when a patient should be considered for referral to neuromuscular specialists is provided.
References
More filters
Journal ArticleDOI
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial
Jacques E. Rossouw,Garnet L. Anderson,Ross L. Prentice,Andrea Z. LaCroix,Charles Kooperberg,Marcia L. Stefanick,Rebecca D. Jackson,Shirley A.A. Beresford,Barbara V. Howard,Karen C. Johnson,Jane Morley Kotchen,Judith K. Ockene +11 more
TL;DR: Overall health risks exceeded benefits from use of combined estrogen plus progestin for an average 5.2-year follow-up among healthy postmenopausal US women, and the results indicate that this regimen should not be initiated or continued for primary prevention of CHD.
Journal ArticleDOI
Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
Stephen B. Hulley,Deborah Grady,Trudy L. Bush,Curt D Furberg,David M. Herrington,Betty Riggs,Eric Vittinghoff +6 more
TL;DR: Treatment with oral conjugated equine estrogen plus medroxyprogesterone acetate did not reduce the overall rate of CHD events in postmenopausal women with established coronary disease and the treatment did increase the rate of thromboembolic events and gallbladder disease.
Journal ArticleDOI
Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.
Echt Ds,Philip R. Liebson,Mitchell Lb,Robert W. Peters,Obias-Manno D,Barker Ah,Arensberg D,Baker A,Lawrence S. Friedman,Greene Hl +9 more
TL;DR: There was an excess of deathsDue to arrhythmia and deaths due to shock after acute recurrent myocardial infarction in patients treated with encainide or flecainide.
Journal ArticleDOI
A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction.
TL;DR: Finding and analyzing all therapeutic trials in a given field has become such a difficult and specialized task that the clinical experts called on to summarize the evidence in a timely fashion need access to better databases and new statistical techniques to assist them.
Journal ArticleDOI
Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group.
David Atkins,Martin P Eccles,Signe Flottorp,Gordon H. Guyatt,David Henry,Suzanne Hill,Alessandro Liberati,Dianne L. O'Connell,Andrew D Oxman,Bob Phillips,Holger J. Schünemann,Holger J. Schünemann,Tessa Tan-Torres Edejer,Gunn Elisabeth Vist,John W Williams +14 more
TL;DR: The objective was to critically appraise six prominent systems for grading levels of evidence and the strength of recommendations as a basis for agreeing on characteristics of a common, sensible approach.